Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1998
Net Income	-13.32	-20.28	-13.4	-8.24	-11.44	-15.12	-26.66	-22.05	-19.41	-38.54	Upgrade
Depreciation & Amortization	0.75	0.71	0.42	0.37	0.91	2	2.15	1.18	1.09	0.78	Upgrade
Share-Based Compensation	0.57	0.61	0.61	0.25	0.13	0.36	0.75	1.08	2.04	3.1	Upgrade
Other Operating Activities	-0.85	5.99	2.09	-0.81	3.95	-1.7	1.65	0.25	-4.86	3.16	Upgrade
Operating Cash Flow	-12.85	-12.97	-10.28	-8.43	-5.91	-11.98	-18.13	-19.53	-20.47	-30.33	Upgrade
Capital Expenditures	-0.16	-0.51	-0.08	-0.09	-0.07	-0.13	-0.18	0.06	-0.6	-0.69	Upgrade
Acquisitions	0	0	0	0	5.64	0	-1.2	0	0	0	Upgrade
Other Investing Activities	-	-0.25	-	-0.4	-	-	-	-	-0.01	-0.66	Upgrade
Investing Cash Flow	-0.16	-0.76	-0.08	-0.49	5.57	-0.13	-1.38	0.06	-0.61	-1.34	Upgrade
Share Issuance / Repurchase	5.4	15.83	20.69	5.11	16.45	7.23	23.61	21.47	34.05	23.15	Upgrade
Debt Issued / Paid	-1.61	-1.61	-0.28	-5.42	-3.82	0	-4.72	0	-7.33	-1.96	Upgrade
Other Financing Activities	-0.35	-0.77	-	-	-	-0.07	-2.08	-3.86	-5.92	9.68	Upgrade
Financing Cash Flow	3.45	13.45	20.42	-0.32	12.63	7.17	16.82	17.61	20.8	30.87	Upgrade
Exchange Rate Effect	0	0	0	0	-0	0.02	0.01	0.08	0	-0.09	Upgrade
Net Cash Flow	-9.57	-0.28	10.05	-9.25	12.29	-4.92	-2.69	-1.78	-0.28	-0.88	Upgrade
Free Cash Flow	-13.01	-13.48	-10.36	-8.53	-5.97	-12.11	-18.31	-19.47	-21.07	-31.02	Upgrade
Free Cash Flow Margin	-264.83%	-6018.30%	-	-2814.19%	-85.35%	-405.90%	-285.60%	-171.08%	-180.70%	-408.24%	Upgrade
Free Cash Flow Per Share	-4.14	-7.70	-12.85	-28.87	-64.70	-1044.17	-4237.64	-8440.52	-16825.37	-43127.64	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).